LAS VEGAS — GB Sciences, Inc. (formerly known as Growblox
LAS VEGAS — GB Sciences, Inc. (formerly known as Growblox Sciences, Inc.) (OTCQB: GBLX) submits offer to Louisiana State University (LSU) to act as the LSU licensed operator of their medical cannabis production facility as outlined in the Alison Neustrom Act (hereinafter referred to as the “Act”).
The offer would enable GB Sciences to be the sole vendor of cannabis and extracted cannabis compounds on behalf of LSU for the patients of Louisiana. LSU and Southern University have the only two licenses granted by the State of Louisiana to cultivate, distribute, and sell medical cannabis.
The Act specifically authorizes the LSU AgCenter to conduct research on medical cannabis. The AgCenter will operate a separate research division for independent research. The research division may operate alongside and in the same facility as the Production Entity’s commercial operation, which will produce therapeutic medical cannabis products for qualified patients of Louisiana. If GB Sciences is selected to work with LSU, it will have first rights to commercialize any inventions or discovery of research center. GB Sciences is looking forward to the prospect of working with LSU on GB Sciences’ cannabis tissue propagation technology.
The facility will serve the approximate five million people who live in the state of Louisiana. The cultivation plant will contain a minimum of a 5,000 square foot research lab.
In order to fulfill the requirements of the application, GB Sciences is raising two million dollars in bonds. The bonds will collateralize a required bid bond associated with the offer to LSU. This is an open bid process with only a few offers due to the one million dollar bid bond provision. The license and partnership is for the development of new cannabis based medical compounds and tissue propagation development for new cannabis drug discovery to advance the GB Sciences (GBLX) patented formulations toward FDA approved Clinical Trials.
GB Sciences, Inc. (GBLX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Halloween at Circus Circus: A New Spin on Family Fun Ah, Circus Circus Las Vegas. It's that place that’s managed to blend screaming kids, excited parents, and a flurry of flashing lights into something resembling an amusement park—on the Strip no less. Now, they're turning up the heat for Halloween. Yup, they're rolling out half-price Midway games and Adventuredome...
Continue Reading
Bringing SKE's Flair to London's Music Scene Well, folks, hold onto your hats—SKE's thrown its weight behind IRONWORKS London, extending its reach deeper into the UK's electronic music scene. This ain't just another gig; we're talking about the second time SKE is flexing its sponsorship muscles in the UK music arena, officially angling for the vape category spotlight....
Continue Reading
Potential Pitfalls in Pending Transactions In the tangled world of corporate deals, not every handshake benefits everyone around the table. This time, it's Surgery Partners, Range Resources, and Penske Automotive Group finding themselves under legal scrutiny. We'll dig into why Nasdaqq:SGRY, Nyse:RRC, and Nyse:PAG, might have some explaining to do. Whose Pockets Are...
Continue Reading
Anthropic's Entrance: A New Horizon in AI Investment Gritty times afoot in the tech trenches, and Anthropic's prepping for an IPO ain't just a blip on the radar—it's a sledgehammer moment for folks keeping their eye on AI. Leverage Shares, through their Themes branch, are sniffing out opportunities to create new investment products. They're tiptoeing around launching...
Continue Reading
Skechers Shareholders Stirring Over Lawsuit A fresh wave of legal antics is crashing at the shores of Skechers U.S.A., Inc. (NYSE: SKX) as frustrated shareholders mobilize against the footwear juggernaut. We're talking about a class action lawsuit here, folks, aimed at shaking down some clarity—or maybe just some cold, hard cash—from this bruiser over some sketchy...
Continue Reading
Revolutionizing Black Friday Planning Off we go, diving headfirst into the chaotic whirlpool that is Black Friday shopping. Slickdeals seems to think they’ve got the golden ticket with The Sift, and I can't say they're wrong. Instead of the traditional paper ad scans we've been sifting through since the dawn of time, The Sift brings all announced deals into one...
Continue Reading
Beta Bionics' Investors in a Bind: Lead Plaintiff Opportunity Looms Alright, folks, it’s time to size up the situation at Beta Bionics, Inc. (NASDAQ: BBNX). If you're holding onto their stock and nursing some serious losses, you're not alone. The clock's ticking on the November 3, 2026 deadline to step up and lead the charge in a class action lawsuit. What's the Fuss...
Continue Reading
Pioneering Emergency Management Standards The landscape of emergency management just got a shakeup, folks. PG&E, an energy utility giant that powers the lives of over 16 million Californians, bagged a distinction that doesn’t roll around every day—indeed, the first of its caliber in the utility sector. Earning accreditation from the big dogs at the Emergency...
Continue Reading
Alfa Laval Banks on a New Financial Horizon Forget your morning rituals, Alfa Laval just pulled off a maneuver that's got industry tongues wagging. Thanks to a new EUR 1 billion revolving credit facility, they've bolstered their financial defenses, setting a robust foundation for the future. The facility, no dink-and-dunk affair, carries an initial five-year maturity. And...
Continue Reading
The Anticipation Builds for TDS and Array's Q3 Results Financial markets are buzzing like a caffeine-fueled trading floor about the upcoming third quarter results from Telephone and Data Systems, Inc. (NYSE: TDS) and its partner in digital endeavors, Array Digital Infrastructure, Inc. (NYSE: AD). Set to go live with their numbers on November 6, 2026, these companies are...
Continue Reading
Top 5 Most Recently Viewed Articles
Alzamend Neuro Announces $6.5 Million ATM Offering Alzamend Neuro, Inc., a dedicated biopharmaceutical firm aimed at developing innovative treatments for various neurological and psychiatric disorders, has made a significant move by entering an At-the-Market (ATM) issuance sales agreement with Ascendiant Capital Markets, LLC. This development marks a proactive strategy to...
Continue Reading
Celebrating a Remarkable Investment Success 10 Federal has achieved a significant milestone with the recent sale of Mountaineer Village Apartments, located in Boone. This student housing community has served students well, showcasing the firm's capabilities in managing real estate assets. The community has been a vital part of the company's portfolio, leading to a...
Continue Reading
Electrophysiology Market Size & Growth Outlook According to recent insights from SNS Insider, the global Electrophysiology market is witnessing tremendous growth. Valued initially at approximately USD 12.89 billion, the market is projected to surge to USD 33.72 billion by 2033. This growth represents a compound annual growth rate (CAGR) of 12.79% from 2026 to 2033. The...
Continue Reading
What’s Happening with NIO's Options Activity? Recently, significant bullish activities have been observed in the options market for NIO, indicating a potential shift among traders. An analysis of recent options trades reveals that there were a total of 17 unusual trades concerning NIO (NYSE: NIO). Interestingly, the data shows a nearly balanced sentiment, with 47% of...
Continue Reading
Comerica Bank's Commitment to Women Entrepreneurs Comerica Bank is proud to announce its contribution of $150,000 this October, supporting organizations that empower female entrepreneurs across several locations. This donation aligns with the celebration of National Women's Small Business Month, highlighting the importance of women's contributions to the economy....
Continue Reading